Union Health Minister J. P. Nadda visited All India Institute of Medical Sciences (AIIMS), Bibinagar, near Hyderabad, Telangana, on Thursday, 9 July 2026, and chaired a review meeting to assess the institute's progress and ongoing development works.

Context

Nadda noted that AIIMS Bibinagar, established in 2022 with an investment of over ₹1,100 crore, has become fully operational within just four years. The institute now serves nearly 1,800 patients daily and has extended telemedicine services to over 1.56 lakh people since becoming functional.

The minister also highlighted the institute's academic output, stating that AIIMS Bibinagar has published over 1,156 research papers so far — a figure he described as reflecting 'big strides in research' alongside its clinical workload.

Policy Backdrop

AIIMS Bibinagar traces its roots to the Pradhan Mantri Swasthya Suraksha Yojana (PMSSY), a central scheme first launched in 2003 to set up new AIIMS across states and address regional imbalances in tertiary healthcare. The Union Cabinet approved the Bibinagar institute as part of a batch of six additional AIIMS sanctioned in 2015.

Subsequent phases of PMSSY between 2018 and 2021 sanctioned further AIIMS and upgraded government medical colleges nationwide. The Union government has since expanded the original single AIIMS in New Delhi into a network of more than twenty institutes, most approved after 2014, to decentralise high-end medical education, research, and tertiary care.

Stakeholders and Impact

For patients in Telangana and surrounding southern states, AIIMS Bibinagar reduces the need to travel to metropolitan centres such as New Delhi or Mumbai for advanced care. The institute's telemedicine reach — covering over 1.56 lakh consultations — signals an effort to extend specialist services beyond its physical campus to underserved populations.

Medical researchers and healthcare professionals at the institute benefit from a growing research ecosystem: the published output of over 1,156 papers positions AIIMS Bibinagar as an emerging academic medical centre rather than solely a clinical facility.

Nadda framed the achievements within the broader national health agenda, stating that 'under the leadership of Prime Minister Narendra Modi, India's healthcare sector has witnessed unprecedented progress over the past decade,' and that the institute's growth 'will further strengthen our vision of a Healthy India by delivering quality tertiary care to the people.'

What's Next

Operational reviews of the remaining new AIIMS under PMSSY are expected to continue, with budget utilisation reports likely to draw scrutiny in parliamentary sessions. The progress at AIIMS Bibinagar may serve as a benchmark as the Union government evaluates outcomes across the broader network of new institutes.

As the PMSSY network matures, the focus is expected to shift from construction and operationalisation to sustained quality metrics — patient outcomes, research rankings, and faculty strength — at each of the new AIIMS campuses.